Search

Michael C. Wilson

Examiner (ID: 15368, Phone: (571)272-0738 , Office: P/1632 )

Most Active Art Unit
1632
Art Unit(s)
1632, 1633, 1638
Total Applications
1660
Issued Applications
561
Pending Applications
276
Abandoned Applications
841

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18770838 [patent_doc_number] => 20230365638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-16 [patent_title] => ETV2 AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/309466 [patent_app_country] => US [patent_app_date] => 2023-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8152 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18309466 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/309466
ETV2 AND USES THEREOF Apr 27, 2023 Abandoned
Array ( [id] => 19525804 [patent_doc_number] => 20240349706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-24 [patent_title] => Novel Animal Model for Autoimmune Disease [patent_app_type] => utility [patent_app_number] => 18/305342 [patent_app_country] => US [patent_app_date] => 2023-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5696 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18305342 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/305342
Novel Animal Model for Autoimmune Disease Apr 21, 2023 Pending
Array ( [id] => 19262743 [patent_doc_number] => 20240206438 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-27 [patent_title] => SIMPLE AND RAPID CONSTRUCTION OF RAT MODEL OF CONSTIPATION AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/301271 [patent_app_country] => US [patent_app_date] => 2023-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5992 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18301271 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/301271
SIMPLE AND RAPID CONSTRUCTION OF RAT MODEL OF CONSTIPATION AND USE THEREOF Apr 16, 2023 Abandoned
Array ( [id] => 18737939 [patent_doc_number] => 20230346841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => COMPOSITIONS, METHODS AND USES FOR IN VITRO AND IN VIVO GENERATION OF FUNCTIONAL THYMIC TISSUE [patent_app_type] => utility [patent_app_number] => 18/132164 [patent_app_country] => US [patent_app_date] => 2023-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13525 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18132164 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/132164
COMPOSITIONS, METHODS AND USES FOR IN VITRO AND IN VIVO GENERATION OF FUNCTIONAL THYMIC TISSUE Apr 6, 2023 Pending
Array ( [id] => 18806911 [patent_doc_number] => 20230381244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-30 [patent_title] => Methods and Systems for Improved Therapies Using Photo-Activated Stem Cells [patent_app_type] => utility [patent_app_number] => 18/295661 [patent_app_country] => US [patent_app_date] => 2023-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17489 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18295661 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/295661
Methods and Systems for Improved Therapies Using Photo-Activated Stem Cells Apr 3, 2023 Abandoned
Array ( [id] => 18597600 [patent_doc_number] => 20230272397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-31 [patent_title] => METHODS FOR IMPROVING THE HEALTH OF PORCINE SPECIES BY TARGETED INACTIVATION OF CD163 [patent_app_type] => utility [patent_app_number] => 18/192492 [patent_app_country] => US [patent_app_date] => 2023-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45082 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18192492 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/192492
Methods for improving the health of porcine species by targeted inactivation of CD163 Mar 28, 2023 Issued
Array ( [id] => 18739941 [patent_doc_number] => 20230348910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => COMPOSITIONS AND METHODS FOR GENETIC MODIFICATION AND TARGETING [patent_app_type] => utility [patent_app_number] => 18/188315 [patent_app_country] => US [patent_app_date] => 2023-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36941 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18188315 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/188315
COMPOSITIONS AND METHODS FOR GENETIC MODIFICATION AND TARGETING Mar 21, 2023 Abandoned
Array ( [id] => 18451590 [patent_doc_number] => 20230192868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => ANTI-IGF-I RECEPTOR ANTIBODY [patent_app_type] => utility [patent_app_number] => 18/177718 [patent_app_country] => US [patent_app_date] => 2023-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26723 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18177718 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/177718
ANTI-IGF-I RECEPTOR ANTIBODY Mar 1, 2023 Abandoned
Array ( [id] => 18522149 [patent_doc_number] => 20230232797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-27 [patent_title] => NON-HUMAN ANIMALS COMPRISING A HUMANIZED ALBUMIN LOCUS [patent_app_type] => utility [patent_app_number] => 18/175010 [patent_app_country] => US [patent_app_date] => 2023-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46111 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18175010 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/175010
Method of using a genetically modified mouse that expresses human albumin Feb 26, 2023 Issued
Array ( [id] => 20025164 [patent_doc_number] => 20250163386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-22 [patent_title] => Cerebrovascular-Tumor-On-A-Chip [patent_app_type] => utility [patent_app_number] => 18/838519 [patent_app_country] => US [patent_app_date] => 2023-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18838519 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/838519
Cerebrovascular-Tumor-On-A-Chip Feb 14, 2023 Pending
Array ( [id] => 19110413 [patent_doc_number] => 20240122163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-18 [patent_title] => A METHOD FOR CONSTRUCTING A COFILIN-1 TRANSGENIC MODEL AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/165038 [patent_app_country] => US [patent_app_date] => 2023-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3397 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18165038 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/165038
A METHOD FOR CONSTRUCTING A COFILIN-1 TRANSGENIC MODEL AND USE THEREOF Feb 5, 2023 Pending
Array ( [id] => 18522998 [patent_doc_number] => 20230233651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-27 [patent_title] => MATERIALS AND METHODS FOR TREATMENT OF TITIN-BASED MYOPATHIES AND OTHER TITINOPATHIES [patent_app_type] => utility [patent_app_number] => 18/162850 [patent_app_country] => US [patent_app_date] => 2023-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28090 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18162850 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/162850
Guide RNA for repairing a mutant human titin gene using CRISPR technology Jan 31, 2023 Issued
Array ( [id] => 18417716 [patent_doc_number] => 20230172172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => MOUSE MODEL OF DITRA DISEASE AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/159414 [patent_app_country] => US [patent_app_date] => 2023-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18072 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159414 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/159414
Mouse model of DITRA disease and uses thereof Jan 24, 2023 Issued
Array ( [id] => 18595299 [patent_doc_number] => 20230270087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-31 [patent_title] => Method for Constructing Ptgds Gene Knockout Rat Model with Spontaneous Kidney Yin Deficiency [patent_app_type] => utility [patent_app_number] => 18/155865 [patent_app_country] => US [patent_app_date] => 2023-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6838 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18155865 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/155865
Method for Constructing Ptgds Gene Knockout Rat Model with Spontaneous Kidney Yin Deficiency Jan 17, 2023 Pending
Array ( [id] => 18612627 [patent_doc_number] => 20230279359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-07 [patent_title] => WNT PATHWAY STIMULATION IN REPROGRAMMING SOMATIC CELLS WITH NUCLEAR REPROGRAMMING FACTORS [patent_app_type] => utility [patent_app_number] => 18/091888 [patent_app_country] => US [patent_app_date] => 2022-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30401 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18091888 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/091888
WNT PATHWAY STIMULATION IN REPROGRAMMING SOMATIC CELLS WITH NUCLEAR REPROGRAMMING FACTORS Dec 29, 2022 Abandoned
Array ( [id] => 18610962 [patent_doc_number] => 20230277692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-07 [patent_title] => HUMANIZED RODENTS FOR TESTING THERAPEUTIC AGENTS [patent_app_type] => utility [patent_app_number] => 18/089267 [patent_app_country] => US [patent_app_date] => 2022-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74389 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18089267 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/089267
HUMANIZED RODENTS FOR TESTING THERAPEUTIC AGENTS Dec 26, 2022 Pending
Array ( [id] => 18615706 [patent_doc_number] => 20230282445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-07 [patent_title] => METHOD OF NUCLEAR REPROGRAMMING [patent_app_type] => utility [patent_app_number] => 18/146644 [patent_app_country] => US [patent_app_date] => 2022-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12372 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18146644 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/146644
METHOD OF NUCLEAR REPROGRAMMING Dec 26, 2022 Pending
Array ( [id] => 18466084 [patent_doc_number] => 20230200363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-29 [patent_title] => TRANSGENIC FLUORESCENT ORNAMENTAL AMPHIBIANS [patent_app_type] => utility [patent_app_number] => 18/085601 [patent_app_country] => US [patent_app_date] => 2022-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7120 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -36 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18085601 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/085601
TRANSGENIC FLUORESCENT ORNAMENTAL AMPHIBIANS Dec 20, 2022 Abandoned
Array ( [id] => 18469256 [patent_doc_number] => 20230203540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-29 [patent_title] => METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED TARGETED INTEGRATION OF TRANSGENES INTO MAMMALIAN LIVER CELLS [patent_app_type] => utility [patent_app_number] => 18/085420 [patent_app_country] => US [patent_app_date] => 2022-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21566 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18085420 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/085420
METHODS AND COMPOSITIONS FOR NUCLEASE-MEDIATED TARGETED INTEGRATION OF TRANSGENES INTO MAMMALIAN LIVER CELLS Dec 19, 2022 Abandoned
Array ( [id] => 19709580 [patent_doc_number] => 20250019722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-16 [patent_title] => COMPOSITIONS COMPRISING KOZAK SEQUENCES SELECTED FOR ENHANCED EXPRESSION [patent_app_type] => utility [patent_app_number] => 18/716643 [patent_app_country] => US [patent_app_date] => 2022-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15099 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18716643 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/716643
COMPOSITIONS COMPRISING KOZAK SEQUENCES SELECTED FOR ENHANCED EXPRESSION Dec 8, 2022 Pending
Menu